Global Onychomycosis Treatment Market Size, Share, Growth Analysis Report - Forecast 2034

Onychomycosis Treatment Market: Industry Perspective

The global onychomycosis treatment market size was worth around USD 3.36 Billion in 2024 and is predicted to grow to around USD 5.17 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 4.4% between 2025 and 2034.

The report analyzes the global onychomycosis treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the onychomycosis treatment industry.

Request Free Sample

Onychomycosis Treatment Market: Overview

Onychomycosis, also known as tinea unguium, is a toenail or fingernail fungal disease that causes infection of the ring over the nails. Moreover, trichophyton rubrum and trichophyton mentagrophytes are common fungal strains that cause dermatophytic onychomycosis. In addition, other organisms that transmit the disease are yeasts and non-dermatophyte molds. The major source of onychomycosis is public places such as gymnasiums, swimming pools, and others polluted with disease-causing fungal agents. In addition, fungal infection is caused by the continuous use of footwear for a longer duration and the touch of toenails on wet surfaces. Increasing disease incidences are apparent in athletes due to constant shoe use, nail sweating, and traumatic nail injuries.

Key Insights

• As per the analysis shared by our research analyst, the global onychomycosis treatment market is estimated to grow annually at a CAGR of around 4.4% over the forecast period (2025-2034).
• Regarding revenue, the global onychomycosis treatment market size was valued at around USD 3.36 Billion in 2024 and is projected to reach USD 5.17 Billion by 2034.
• The onychomycosis treatment market is projected to grow at a significant rate due to increasing prevalence of onychomycosis, rising awareness of nail health and potential complications, a growing aging and diabetic population, and advancements in treatment options including novel drugs and non-invasive therapies like laser treatment.
• Based on Treatment, the Drugs segment is expected to lead the global market.
• On the basis of Indication, the Distal Subungual Onychomycosis segment is growing at a high rate and will continue to dominate the global market.
• Based on the Age Group, the 0-18 Years segment is projected to swipe the largest market share.
• By Gender, the Male segment is expected to dominate the global market.
• In terms of Distribution Channel, the Institutional Sales segment is anticipated to command the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Onychomycosis Treatment Market: Growth Factors

Surge in the disease conditions can prop up the global market demand over 2023-2030

The rise in the occurrence of onychomycosis along with a need for effectively treating it will steer the expansion of the global onychomycosis treatment market. A prominent increase in the cases of HIV, peripheral artery disease, and diabetes will steer the growth of the market across the globe. Surging aging populace prone to chronic diseases will fuel the expansion of the market globally. Huge demand for precision onychomycosis therapy as well as laser therapy for treating the disease will scale up the market landscape globally. Furthermore, chronic conditions prevalent among the millennial population base and adults due to their exposure to public swimming pools and wearing of tight clothes & socks can uplift the growth of the global market. Additionally, a rise in the approvals of new products will favorably impact the expansion of the global market. In 2022, Zydus Lifesciences Limited, a key pharmaceutical firm based in India, received a green signal from the U.S. FDA for promoting its antifungal efinaconazole topical solutions.

Onychomycosis Treatment Market: Restraints

Lack of knowhow about onychomycosis treatment among individuals can create inhibitions on the global industry expansion by 2030

Low awareness about treating onychomycosis along with patients ignoring the symptoms can impede the growth of the global onychomycosis treatment industry. Additionally, side effects caused due to medicines used for treating onychomycosis can impede the expansion of the global industry size.

Onychomycosis Treatment Market: Opportunities

An increment in the investments for treating onychomycosis to embellish the expansion of the global market over 2023-2030

An increase in the fund allocation by pharmaceutical firms for research activities related to early diagnosis and treatment of onychomycosis will open new growth opportunities for the global onychomycosis market. A large number of market players are allocating significant funds for developing new drugs for effectively treating the disease in its initial phase, thereby boosting the global market demand. Focus on developing antifungal therapies will steer the growth of the market across the globe.

Onychomycosis Treatment Market: Challenges

Stringent government legislation over the use of prescribed drugs for treating onychomycosis can prove to be a big challenge for the global industry

Strict government laws concerning the use of antibiotics for treating onychomycosis can prove a challenge for the global onychomycosis treatment industry.

Onychomycosis Treatment Market: Segmentation

The global onychomycosis treatment market is sectored into type, treatment, distribution channel, and region.        

In type terms, the global onychomycosis treatment market is segregated into candida onychomycosis, proximal sublingual onychomycosis, white superficial onychomycosis, distal sublingual onychomycosis, and others segments. Furthermore, the proximal subungual onychomycosis segment, which amassed nearly half of the global market revenue share in 2022, is anticipated to register the fastest CAGR in the upcoming years. The growth of the segment during the estimated timeframe can be due to the humongous need for treating proximal subungual onychomycosis with the help of medicines.

Based on the distribution channel, the global onychomycosis treatment industry is sectored into retail pharmacies, hospital pharmacies, and others segments. Moreover, the hospital pharmacies segment, which garnered a major chunk of the global industry share in 2022, is predicted to lead the global industry over the upcoming years. The segmental expansion over the assessment timeline can be subject to the easy availability of drugs in hospitals. An increase in the number of dermatologists as well as podiatrists will steer the segmental surge.

Based on the treatment, the global onychomycosis treatment market is divided into topical therapy, drug treatment, and others segments.

By Age Group, the global onychomycosis treatment market is split into 0-18 Years, 18-39 Years, 40-64 Years, 65 Years & Above.

In terms of Gender, the global onychomycosis treatment market is categorized into Male, Female.

Onychomycosis Treatment Market: Report Scope

Onychomycosis Treatment Market: Regional Analysis

North America is predicted to maintain its dominant position in the global onychomycosis treatment market over the prognosis period

North America, which contributed about 58% of the global onychomycosis treatment market revenue in 2022, will be a leading region over the analysis timespan. In addition to this, the regional market surge can be attributed to growing cases of onychomycosis and the availability of improved medical treatments for the disease in countries such as the U.S. The presence of giant firms in the U.S. will proliferate the regional market earnings in the years to come. A surge in the number of diabetics in countries such as the U.S. will pave the way for the growth of the market in the sub-continent in the near future.

The European onychomycosis treatment industry is set to register the fastest CAGR in the upcoming years owing to favorable government initiatives promoting personalized treatment for onychomycosis. For instance, the British Association of Dermatologists provides data on patients who have a fungal infection of nails. Such initiatives are likely to create new growth opportunities for the regional industry.

Onychomycosis Treatment Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the onychomycosis treatment market on a global and regional basis.

The global onychomycosis treatment market is dominated by players like:

• Bausch Health Companies Inc.
• GSK plc
• Abbott
• Pfizer Inc.
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• Cipla Inc.
• Merck & Co. Inc.
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Janssen Pharmaceuticals Inc.
• GlaxoSmithKline plc
• Dr. Reddy's Laboratories

The global onychomycosis treatment market is segmented as follows;

By Treatment

• Drugs
• Lasers
• Photodynamic Therapy

By Indication

• Distal Subungual Onychomycosis
• White Superficial Onychomycosis
• Proximal Subungual Onychomycosis
• Candidal Onychomycosis
• Total Dystrophic Onychomycosis

By Age Group

• 0-18 Years
• 18-39 Years
• 40-64 Years
• 65 Years & Above

By Gender

• Male
• Female

By Distribution Channel

• Institutional Sales
• Retail Sales

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America